ArabFinance: Arab Drug Company (ADCI) reported a 114% Year on Year increase in its net profit for the fiscal year (FY) 2019/2020, according to the company's July 12th disclosure filed to the Egyptian Exchange.
Net profit reached EGP 120.020 million in the FY 2019/2020, compared from EGP 56.099 million posted a year earlier.
In the first half of FY 2019/2020, the company posted a net profit of EGP 45.117 million, a 204% increase from EGP 22.098 million reported in the corresponding period a year earlier.
Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
